CONSORT: Different End-Points of Preoperative Nutrition and Outcome of Bowel Resection of Crohn Disease: A Randomized Clinical Trial
- PMID: 26200619
- PMCID: PMC4603011
- DOI: 10.1097/MD.0000000000001175
CONSORT: Different End-Points of Preoperative Nutrition and Outcome of Bowel Resection of Crohn Disease: A Randomized Clinical Trial
Abstract
Nutritional therapy cannot only improve nutritional status but also reduce bowel inflammation in Crohn disease (CD). The benefits of preoperative nutritional therapy on outcomes of surgery for CD have been demonstrated. However, the ideal end-points of preoperative nutrition in CD remain elusive. We conducted this study to figure out whether improvement of malnutrition or reduction of inflammation is the better end-point of preoperative nutrition for CD. This was a prospective, randomized study. All patients enrolled received preoperative nutrition with different end-points (improvement of malnutrition, IOM, or reduction of inflammation, ROI). The end-points were defined using serum albumin and body weight gain, and serum C-reactive protein (CRP), respectively. Postoperative complications, rate of fecal diversion, and postoperative recurrence of the disease were compared. A total of 108 patients were randomized and 91 patients (44 in IOM group and 47 in ROI group) completed this study. It took 25.57 ± 11.68 days to achieve ROI and 45.29 ± 18.47 days for IOM (P = 0.0023). After nutritional therapy, serum CRP, CDAI, and serum albumin in both groups improved significantly. But patients in the IOM group had a higher albumin level and body weight gain compared with ROI group (P = 0.0026, P < 0.0001). When comparing postoperative complications, rate of fecal diversion, and postoperative recurrence, no significant differences were noted. Compared with IOM, ROI as the end-point of preoperative nutrition had the same benefits on operative outcomes in CD patients undergoing resection, but could be achieved in a shorter time (NCT01540942).
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

Similar articles
-
Impact of Preoperative Exclusive Enteral Nutrition on Postoperative Complications and Recurrence After Bowel Resection in Patients with Active Crohn's Disease.World J Surg. 2016 Aug;40(8):1993-2000. doi: 10.1007/s00268-016-3488-z. World J Surg. 2016. PMID: 26940580
-
Body mass index is a practical preoperative nutritional index for postoperative infectious complications after intestinal resection in patients with Crohn's disease.Medicine (Baltimore). 2017 Jun;96(23):e7113. doi: 10.1097/MD.0000000000007113. Medicine (Baltimore). 2017. PMID: 28591060 Free PMC article.
-
Does preoperative enteral or parenteral nutrition reduce postoperative complications in Crohn's disease patients: a meta-analysis.Eur J Gastroenterol Hepatol. 2018 Sep;30(9):997-1002. doi: 10.1097/MEG.0000000000001162. Eur J Gastroenterol Hepatol. 2018. PMID: 29738326 Review.
-
Preoperative albumin and surgical site identify surgical risk for major postoperative complications.JPEN J Parenter Enteral Nutr. 2003 Jan-Feb;27(1):1-9. doi: 10.1177/014860710302700101. JPEN J Parenter Enteral Nutr. 2003. PMID: 12549591
-
Nutrition optimization prior to surgery.Nutr Clin Pract. 2014 Feb;29(1):10-21. doi: 10.1177/0884533613517006. Epub 2013 Dec 17. Nutr Clin Pract. 2014. PMID: 24347529 Review.
Cited by
-
Exclusive enteral nutrition: An optimal care pathway for use in adult patients with active Crohn's disease.JGH Open. 2019 Sep 10;4(2):260-266. doi: 10.1002/jgh3.12256. eCollection 2020 Apr. JGH Open. 2019. PMID: 32280775 Free PMC article.
-
Preoperative Nutritional Conditioning of Crohn's Patients-Systematic Review of Current Evidence and Practice.Nutrients. 2017 Jun 1;9(6):562. doi: 10.3390/nu9060562. Nutrients. 2017. PMID: 28587182 Free PMC article.
-
Nutritional status as a predictor of hospitalization in inflammatory bowel disease: A review.World J Gastrointest Pharmacol Ther. 2019 Mar 7;10(2):50-56. doi: 10.4292/wjgpt.v10.i2.50. World J Gastrointest Pharmacol Ther. 2019. PMID: 30891328 Free PMC article. Review.
-
Exploring gut microbiota as a novel therapeutic target in Crohn's disease: Insights and emerging strategies.World J Gastroenterol. 2025 Jan 14;31(2):100827. doi: 10.3748/wjg.v31.i2.100827. World J Gastroenterol. 2025. PMID: 39811502 Free PMC article. Review.
-
Postoperative diarrhea in Crohn's disease: Pathogenesis, diagnosis, and therapy.World J Clin Cases. 2023 Jan 6;11(1):7-16. doi: 10.12998/wjcc.v11.i1.7. World J Clin Cases. 2023. PMID: 36687182 Free PMC article. Review.
References
-
- Rungoe C, Langholz E, Andersson M, et al. Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979–2011. Gut 2014; 63:1607–1616. - PubMed
-
- Duepree HJ, Senagore AJ, Delaney CP, et al. Advantages of laparoscopic resection for ileocecal Crohn's disease. Dis Colon Rectum 2002; 45:605–610. - PubMed
-
- Melton GB, Stocchi L, Wick EC, et al. Contemporary surgical management for ileosigmoid fistulas in Crohn's disease. J Gastrointest Surg 2009; 13:839–845. - PubMed
-
- Goyer P, Alves A, Bretagnol F, et al. Impact of complex Crohn's disease on the outcome of laparoscopic ileocecal resection: a comparative clinical study in 124 patients. Dis Colon Rectum 2009; 52:205–210. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous